With our efficient and flexible staffing models, Med Communications is equipped to navigate uncertainty while maintaining stability for our clients. Our skilled Scientific Communications team of healthcare professionals is agile…
In recent years, digital innovations have led to reimagined customer communications in the pharmaceutical industry. Interactive standard responses offer an enriched presentation of data that leads to a more tailored…
Advisory Boards provide life science companies with the unique opportunity to strategically engage with a forum of Key Opinion Leaders (KOLs) or Key External Experts (KEEs) on a range of…
AMCP formulary dossiers provide managed care organizations and health care decision makers with the information they need for formulary and medical policy coverage or reimbursement considerations. These dossiers include comprehensive…
Med Communications’ Scientific Communications Development and Review team identified significant accuracy issues and referencing errors during a routine review of a client’s existing field medical training slide decks. A rare…
Experience matters, particularly when it comes to producing high-quality, balanced scientific documents. Strict regulations govern every aspect of the U.S. drug development and marketing process to ensure that accurate, fair-balanced,…
Our highly skilled Scientific Communications team of healthcare professionals leveraged their collected knowledge to meet our client’s unique standard response and literature database needs. Our newest case study focuses on…
Med Communications’ expertise in implementing and managing reference libraries helped a client increase efficiency, which resulted in overall cost savings. A pharma client needed Med Communications’ support to implement a…
In the Med Affairs world, the identification, tiering, and mapping of Key Opinion Leaders (KOLs), also known as Key External Experts (KEEs), is a critical initial step in the dissemination…
Promotional review is traditionally accomplished by groups of professionals who meet a few times per week to review assets. It generally takes several weeks to approve an asset, and sometimes…
